Summary
For Year 2026-27, Suven Life Sciences reports the following shareholding: Total Promoters at 70.15%, Mutual Fund at 1.79%, Insurance at 0%, Foreign Institutional Investors at 0.91%, Domestic Institutional Investors at 2.83%, and Retail at 24.32%. This breakdown provides a quick snapshot of ownership distribution for Suven Life Sciences in 2026-27.
Suven Life Sciences FAQs
As of 04-2026, the promoter shareholding in Suven Life Sciences stands at 70.15% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Suven Life Sciences is 0.91% and 2.83% respectively.
The retail shareholding of the Suven Life Sciences is 24.32%.
Changes in shareholding patterns of Suven Life Sciences can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Suven Life Sciences are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
